Alexza Pharmaceuticals Inc. Development Agreements
3 Contracts & Agreements
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. In December 2009, we submitted an NDA... (Filed With SEC on March 15, 2011)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. In December 2009, we submitted an NDA... (Filed With SEC on March 15, 2011)
- AZ-004 (Staccato loxapine). We are developing AZ-004 for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. In December 2009, we submitted an NDA... (Filed With SEC on March 15, 2011)
